The Promise of RNAi Therapeutics for Cardiovascular Disease Treatment

3 weeks ago 1
Kevin Fitzgerald from Alnylam Pharmaceuticals explains the potential of RNA interference for treating disease and highlights recent clinical trial successes.
Read Entire Article